For the latest
cancer COVID-19 resources, click on this link
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Brain & nervous system
Sign up for latest coverage
Submit your event
cancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Prevention & screening
Middle East and North Africa
Central America and the Caribbean
Australia and Oceania
27 - 28 Apr 2020
Virtual Annual Meeting
Atezolizumab as monotherapy or in combination with cobimetinib in biliary tract ...
Dr Mark Yarchoan - John Hopkins Medicine, Baltimore, USA
30 Jul 2020
High mortality among hospital-acquired COVID-19 infection in patients with cance...
Dr Arielle Elkrief - University of Montreal Hospital Research Centre, Montreal, ...
20 Jul 2020
Safety and efficacy of CD19/CD22 CAR T cells in children and young adults with r...
Dr Haneen Shalabi - National Cancer Institute, NIH, Bethesda, USA
30 Jun 2020
COM701 as a monotherapy and in combination with nivolumab for various advanced s...
Dr. Ecaterina Dumbrava - MD Anderson Cancer Centre, Houston, USA
27 May 2020
COVID-19: Using oncology drugs and surgery during the coronavirus pandemic
Dr. Paolo Ascierto - Istituto Nazionale Tumori, Milan, Italy
21 May 2020
TERAVOLT: Thoracic cancers indicate an unexpectedly high mortality rate in patie...
Dr Heather Wakelee - Stanford University Medical Center, Stanford, USA
21 May 2020
IMPRIME 1: Combination of pembrolizumab and a novel innate immune activator, Imp...
Dr Steven O'Day - John Wayne Cancer Institute, Santa Monica, USA
19 May 2020
A first-of-its-kind prospective study of a multi-cancer blood test to screen and...
Prof Nickolas Papadopoulos - Johns Hopkins Medicine, Baltimore, USA
13 May 2020
I-SPY 2: Durvalumab in combination with olaparib and paclitaxel in high-risk HER...
Prof Lajos Pusztai - Yale Cancer Center, New Haven, USA
5 May 2020
IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients wit...
Prof Grant McArthur - Peter MacCallum Cancer Center, Melbourne, Australia
1 May 2020
Continuous vs intermittent dosing of dabrafenib and trametinib in BRAF mutated m...
Prof Alain Algazi -University of California San Francisco, San Francisco, USA
30 Apr 2020